Changes in anticoagulant prescription in a general hospital in 2008-2018

Changes in anticoagulant prescription in a general hospital in 2008-2018

Aim. To study the structure of anticoagulant prescription in a general hospital to identify trends and contributing factors.Materials and methods. The study was conducted in an urban general hospital. According to retrospective retrieval from electronic health records, total 17,129 patients received...

Full description

Bibliographic Details
Main Authors:	E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev
Format:	Article
Language:	English
Published:	Столичная издательская компания 2021-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	anticoagulants atrial fibrillation venous thromboembolism clinical decision support systems
Online Access:	https://www.rpcardio.online/jour/article/view/2535

Similar Items

Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing
by: A. A. Chernov, et al.
Published: (2018-09-01)

Anticoagulation stewardship: Descriptive analysis of a novel approach to appropriate anticoagulant prescription
by: Maral Koolian, et al.
Published: (2022-08-01)

A call to action for anticoagulation stewardship
by: Allison E. Burnett, et al.
Published: (2022-07-01)

Direct oral anticoagulants. The story of success
by: Róbert Gábor Kiss
Published: (2024-04-01)

Prescription and switching patterns of direct oral anticoagulants in patients with atrial fibrillation
by: Tim A.C. de Vries, et al.
Published: (2024-08-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy
by: João Presume, et al.
Published: (2024-02-01)

Patients with atrial fibrillation and a low risk of thromboembolic events: prescription rate of anticoagulant therapy according to a retrospective analysis
by: M. A. Druzhilov, et al.
Published: (2023-09-01)

Drug utilization evaluation of Rivaroxaban in both inpatient and outpatient settings: Using standard guidelines
by: Afsaneh Vazin, et al.
Published: (2022-12-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

Detection of anticoagulant medication errors by triggers
by: Vitaly A. Otdelenov, et al.
Published: (2024-09-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
by: D. V. Pevzner, et al.
Published: (2023-06-01)

How to level the risk of bleeding while taking anticoagulant therapy in patients with atrial fibrillation?
by: Svetlana A. Berns, et al.
Published: (2022-01-01)

Edoxaban in venous thromboembolism and stroke prevention: an appraisal
by: Proietti M, et al.
Published: (2016-02-01)

Problematic points of anticoagulant therapy for atrial fibrillation in certain Russian regions in 2016- 2019: results of a retrospective big data analysis
by: M. A. Druzhilov, et al.
Published: (2024-10-01)

COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY
by: L. N. Uddin, et al.
Published: (2018-06-01)

Exploring bleeding in oral anticoagulant users: assessing incidence by indications and risk factors in the entire nationwide cohort
by: Jonghyun Jeong, et al.
Published: (2024-09-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01)

Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?
by: Anna Maria Gori, et al.
Published: (2022-12-01)

UK prescribing practice of anticoagulants in patients with chronic kidney disease: a nephrology and haematology-based survey
by: Kathrine Parker, et al.
Published: (2023-01-01)

Abelacimab: A leap forward in anticoagulation with FXI and FXIa Inhibition
by: Hisham A. Badreldin, et al.
Published: (2024-01-01)

Anticoagulation therapy in older patients at risk for syncopal and not-syncopal fall and/or frailty. An AcEMC-GIMSI multidisciplinary consensus document
by: Ivo Casagranda, et al.
Published: (2020-03-01)

Pharmacist Use of a Population Management Dashboard for Safe Anticoagulant Prescribing: Evaluation of a Nationwide Implementation Effort
by: Geoffrey D. Barnes, et al.
Published: (2024-09-01)

Oral anticoagulants: a systematic overview of reviews on efficacy and safety, genotyping, self-monitoring, and stakeholder experiences
by: Claire Khouja, et al.
Published: (2022-10-01)

Assessment and predictors of inappropriate dose of direct oral anticoagulants
by: Mosaad O. Almegren
Published: (2024-01-01)

Efficacy and safety of anticoagulation in thyrotoxic atrial fibrillation: a systematic review and meta-analysis
by: Eng-Loon Tng, et al.
Published: (2022-05-01)

Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria
by: Nikolay Runev, et al.
Published: (2019-06-01)

Frailty and oral anticoagulant prescription in adults with atrial fibrillation: A systematic review
by: Mary Bul, et al.
Published: (2023-06-01)

The Oral Anticoagulants Administration in Elderly Patients with Geriatric Syndromes: What's New?
by: N. M. Vorobyeva, et al.
Published: (2020-12-01)

Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation statusResearch in context
by: Tommaso Bucci, et al.
Published: (2024-12-01)

ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY
by: V. A. Sulimov, et al.
Published: (2015-09-01)

Gaps in guideline-recommended anticoagulation in patients with atrial fibrillation and elevated thromboembolic risk within an integrated healthcare delivery system
by: Sushmita Malik, et al.
Published: (2023-11-01)

EXPERIENCE IN THE USE OF ORAL ANTICOAGULANTS IN OUTPATIENT CLINICS
by: T. V. Voskresenskaya, et al.
Published: (2017-11-01)

Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis
by: Jonathan AC Sterne, et al.
Published: (2017-03-01)

Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real‐World Practice Mirrors Guideline Recommendations
by: Elizabeth Joyce, et al.
Published: (2022-11-01)

Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-11-01)

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study
by: Maxim Grymonprez, et al.
Published: (2023-08-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue
by: O. D. Ostroumova, et al.
Published: (2020-07-01)

Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response
by: Anna Rago, et al.
Published: (2023-01-01)